Domestic developer share of drug approvals

Share of total approved new medicines developed by domestic pharmaceutical companies.

Unit Percent Industry Pharmaceuticals

Records
1
Regions
1
Period
2025
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Domestic developer share of drug approvals

China, 2025

1 observation
52% China · 2025 · DIA · full record
Source: DIA · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2025

Domestic developer share of drug approvals: every record, grouped by region, newest first.
Period Value Source Type
China 1 record
2025 52% DIA · 31 Dec 2025 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
2025 NMPA Approvals: China Clears Record Number of New Drugs DIA 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Domestic developer share of drug approvals. Retrieved from https://statorigin.org/indicators/domestic-developer-share-of-drug-approvals